(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIFCINQUE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LIFCINQUE

ST13

US500000097706678

Class

5

Filing

97706678

Registration

7603473

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

12/17/2024

Trademark type

Word

Nice classes

5

Filing date

12/07/2022

Registration date

12/17/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/17/2024

Last transaction

12/17/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

03

Owner location

Paris, FR

Examiner

FIRST, VIVIAN

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Sanofi

Representatives

Lim, Karen FROSS ZELNICK LEHRMAN & ZISSU, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of inflammationcancermultiple sclerosisautoimmuneinflammatoryblood diseases and disorders

Publications

History of USPTO decisions and trademark events.

20 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/17/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/17/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/15/2024

PUBO

PUBLISHED FOR OPPOSITION

10/15/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/25/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/09/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/09/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/09/2024

ALIE

ASSIGNED TO LIE

09/09/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/15/2024

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

03/27/2024

GNSI

INQUIRY TO SUSPENSION E-MAILED

03/27/2024

CNSI

SUSPENSION INQUIRY WRITTEN

03/27/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

03/15/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

09/13/2023

GNSL

LETTER OF SUSPENSION E-MAILED

09/13/2023

CNSL

SUSPENSION LETTER WRITTEN

09/13/2023

DOCK

ASSIGNED TO EXAMINER

09/13/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/08/2023

NWAP

NEW APPLICATION ENTERED

12/10/2022

Continuous trademark protection

Get notified about every new filing that threatens LIFCINQUE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.